NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 155 filers reported holding NPS PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $43,544,000 | +33.2% | 1,217,320 | -3.2% | 0.22% | +43.0% |
| Q3 2014 | $32,690,000 | -43.0% | 1,257,320 | -27.6% | 0.15% | -34.3% |
| Q2 2014 | $57,399,000 | -30.8% | 1,736,720 | -37.3% | 0.23% | -29.4% |
| Q1 2014 | $82,936,000 | -24.9% | 2,771,000 | -23.8% | 0.33% | -22.7% |
| Q4 2013 | $110,368,000 | -21.9% | 3,635,300 | -18.2% | 0.42% | -26.0% |
| Q3 2013 | $141,395,000 | +79.8% | 4,445,000 | -14.6% | 0.57% | +65.7% |
| Q2 2013 | $78,626,000 | – | 5,207,000 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|